NEULAND LABORATORIES
Back to Balance Sheet
|
NEULAND LABORATORIES Last 5 Year Profit & Loss Account Balance History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Profit & Loss Account Balance | ₹1,343 Cr | ₹995 Cr | ₹752 Cr | ₹465 Cr | ₹308 Cr |
What is the latest Profit & Loss Account Balance ratio of NEULAND LABORATORIES ?
| Year | Profit & Loss Account Balance |
|---|---|
| Mar2026 | ₹1,343 Cr |
| Mar2025 | ₹995 Cr |
| Mar2024 | ₹752 Cr |
| Mar2023 | ₹465 Cr |
| Mar2022 | ₹308 Cr |
How is Profit & Loss Account Balance of NEULAND LABORATORIES Trending?
| Years | Profit & Loss Account Balance | % Change | |
|---|---|---|---|
| Mar2026 | ₹1,343 Cr | 35.05 | |
| Mar2025 | ₹995 Cr | 32.18 | |
| Mar2024 | ₹752 Cr | 61.74 | |
| Mar2023 | ₹465 Cr | 50.99 | |
| Mar2022 | ₹308 Cr | - | |
Compare Profit & Loss Account Balance of peers of NEULAND LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NEULAND LABORATORIES | ₹29,728.5 Cr | 1.3% | 20.9% | 69.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹460,696.0 Cr | 0.5% | -4% | 15.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹246,063.0 Cr | 9.1% | 18.2% | 47.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹191,515.0 Cr | 3.6% | 3.4% | 36.4% | Stock Analytics | |
| CIPLA | ₹114,554.0 Cr | -1.2% | -3.3% | -10.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹98,308.6 Cr | -1.4% | 2.9% | -8% | Stock Analytics | |
NEULAND LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NEULAND LABORATORIES | 1.3% |
20.9% |
69.4% |
| SENSEX | -0.4% |
-0.5% |
-5.8% |
You may also like the below Video Courses